HT Vet
Formerly HT Bioimaging
AI-driven Non-invasive Screening Tool
Startup Pre-Funding Health Tech & Life Sciences Est. 2021
Total Raised
Undisclosed
Pre-Funding
Last Round
Undisclosed
Team
2
11-50 employees
Confidence
90/100
Patents
1
About
HTVET develops an ai-driven solution for early diagnosis of cancer and save pets’ lives, and to empower clinicians to rule out cancer quickly and confidently. HT Vista device is the first AI-driven non-invasive screening tool that allows vets & nurses to rule out cancer of dermal & subcutaneous masses in dogs. By using the company's unique Heat Diffusion Imaging (HDI) technology & cloud-based analysis, vets & nurses are able to rule out cancer on-the-spot and in their own practice. HT Vet LTD is a subsidiary of HT Bioimaging, an Israeli-based company.
Classification
Sector
Health Tech & Life SciencesMedical DevicesDiagnostics Devices
Core Technology
Artificial IntelligenceSimulation & Imaging
Target Customer
ConsumersRecreational & LifestylePet OwnersHealthcare & Life Sciences
Business Model
B2B2CB2B
Tags
dogsdiagnosticspetsveterinarycancer-diagnostics
Details
Product Stage
Customer Development
Employees
11-50
Exact Count
11
Founded
2021
Registrar
516475373
Locations
Ramatayim Road 96, Hod HaSharon, Israel
Links
Website
LinkedIn
Facebook
Admin
Last Update
Apr 25, 2025
Verified by
Yanina Wainscheinker
Claimed
Yes
Missing
funding rounds, news, markets, not claimed
Team (2)
Gideon Barak
Co-founder & Chairman
Founder
Shani Toledano
Co-founder & CEO
Founder
Internal
Created by
Shira Mizrahi (shira@htbioimaging.com)
Created
2023-06-15T00:00:00.000Z
Last editor
Matan Eblagon (matane@sncentral.org)